Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramuscular (IM) injection.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Collaborators: El Galaa Teaching Hospital; Faculty of Medicine, University of Alexandria; University of Alexandria
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• All women who present in active labor for a live birth at the study hospital will be considered for participation in the study

Exclusion Criteria:

• Planned or transferred for delivery via Cesarean section

• Administration of a pre-delivery uterotonic to induce or augment labor

• Unable to provide informed consent due to mental impairment, distress during labor or other reason